Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb 27:5:9.
doi: 10.1186/1477-7517-5-9.

Is low-nicotine Marlboro snus really snus?

Affiliations

Is low-nicotine Marlboro snus really snus?

Jonathan Foulds et al. Harm Reduct J. .

Abstract

Swedish snus is a medium/high nicotine delivery, low-nitrosamine moist smokeless tobacco product that has been estimated to be at least 90% less harmful than smoked tobacco. More men use snus than smoke cigarettes in Sweden, and a quarter of male former smokers quit by switching to snus. Leading multinational cigarette manufacturers have begun test-marketing snus-like products in the United States and other countries. The version of Philip Morris' Marlboro snus currently being marketed in the United States differs from Swedish snus in many ways; it has lower moisture content and pH, but most puzzling is its very low nicotine delivery. Philip Morris, the market-leader in United States cigarette sales, may have designed the product so that it does not satisfy nicotine cravings and fails to enable smokers to switch. In this paper we compare and contrast Swedish snus and Marlboro snus, and speculate as to why Philip Morris may have intentionally designed a product that delivers very low levels of nicotine. We recommend that Philip Morris cease using the term "snus" to refer to dry tobacco products with low nicotine delivery, so that the term be reserved for moist, low-toxin, medium/high nicotine delivery smokeless tobacco products that are qualitatively similar to the leading brands in Sweden.

PubMed Disclaimer

References

    1. Warner KE, Martin EG. Tob Control. 2003/12/09. Vol. 12. 2003. The US tobacco control community's view of the future of tobacco harm reduction; pp. 383–390. - DOI - PMC - PubMed
    1. Broadstock EM. Systematic review of the health effects of modified smokeless tobacco products. New Zealand Health Technology Assessment Report. 2007;10:1–110. http://nzhta.chmeds.ac.nz/publications/smokeless_tobacco.pdf
    1. Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, Nyren O. Lancet. 2007/05/15. Vol. 369. 2007. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study; pp. 2015–2020. - DOI - PubMed
    1. Rodu B, Godshall WT. Harm Reduct J. 2006/12/23. Vol. 3. 2006. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers; p. 37. - DOI - PMC - PubMed
    1. Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, Sweanor D, Warner KE. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev. 2004;13:2035–2042. - PubMed

LinkOut - more resources